Published 2 hours ago • loading... • Updated 2 hours ago

Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production

Eli Lilly CEO reports one-third of new GLP-1 pill patients are using Foundayo as the company expands production capacity and international availability.

1 Articles

RocketNews

Lean Left

Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production

Eli Lilly CEO reports one-third of new GLP-1 pill patients are using Foundayo as the company expands production capacity and international availability.

2 hours ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources1

Leaning Left1Leaning Right0Center0Last Updated2 hours agoBias Distribution

100% Left

Bias Distribution

100% of the sources lean Left

100% Left

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

RocketNews broke the news 2 hours ago on Sunday, September 27, 2026.

Sources are mostly out of (0)

Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production

1 Articles

1 Articles

Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production

Coverage Details

Bias Distribution

Factuality

Ownership

More stories like this

GLP-1 drugs may help sleep apnea, but CPAP remains best treatment: Study

Doctor warns of potential interactions between GLP-1 drugs and cannabis

FDA Approves Lilly's Olumiant (Baricitinib) for Pediatric Patients 12 Years of Age and Older with Severe Alopecia Areata

Weight Loss Pens: Anvisa Investigates Cases of Vision Loss

Popular Weight-Loss Drugs May Play Surprising Role in Cancer Outcomes

Anvisa Prohibits Advertising of the Semavy Slimming Pen

Similar News Topics

Similar News Topics

More stories like this

GLP-1 drugs may help sleep apnea, but CPAP remains best treatment: Study

Doctor warns of potential interactions between GLP-1 drugs and cannabis

FDA Approves Lilly's Olumiant (Baricitinib) for Pediatric Patients 12 Years of Age and Older with Severe Alopecia Areata

Weight Loss Pens: Anvisa Investigates Cases of Vision Loss

Popular Weight-Loss Drugs May Play Surprising Role in Cancer Outcomes

Anvisa Prohibits Advertising of the Semavy Slimming Pen

Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production

1 Articles

1 Articles

Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production

Coverage Details

Bias Distribution Too Big Arrow Icon

Factuality Info Icon

Ownership

More stories like this

GLP-1 drugs may help sleep apnea, but CPAP remains best treatment: Study

Doctor warns of potential interactions between GLP-1 drugs and cannabis

FDA Approves Lilly's Olumiant (Baricitinib) for Pediatric Patients 12 Years of Age and Older with Severe Alopecia Areata

Weight Loss Pens: Anvisa Investigates Cases of Vision Loss

Popular Weight-Loss Drugs May Play Surprising Role in Cancer Outcomes

Anvisa Prohibits Advertising of the Semavy Slimming Pen

Similar News Topics

Similar News Topics

More stories like this

GLP-1 drugs may help sleep apnea, but CPAP remains best treatment: Study

Doctor warns of potential interactions between GLP-1 drugs and cannabis

FDA Approves Lilly's Olumiant (Baricitinib) for Pediatric Patients 12 Years of Age and Older with Severe Alopecia Areata

Weight Loss Pens: Anvisa Investigates Cases of Vision Loss

Popular Weight-Loss Drugs May Play Surprising Role in Cancer Outcomes

Anvisa Prohibits Advertising of the Semavy Slimming Pen

Bias Distribution

Factuality